Centocor's P2P Acquisition

Centocor raised a round of funding on July 23, 1999. Investors include Johnson & Johnson.

Centocor revolutionized the science of immunology and has been a leader in the field of cancer and immune-disorders for over 20 years.…

Articles about Centocor's P2P Acquisition: